Streeting Faces Pressure to Cancel Puberty Blocker Trial
Update: 2025-12-13
Description
Health Secretary Wes Streeting faces mounting pressure to scrap a controversial government-backed trial of puberty-blocking drugs for children with gender incongruence. Critics deem the trial grotesque and state-sanctioned chemical castration, with campaigners launching a legal challenge. The trial, part of the Pathways project, aims to provide puberty blockers to 226 children under 16, despite the Cass review recommending a ban due to lack of safety and effectiveness evidence. Streeting defends the trial, citing the reviews recommendation for a proper study, but faces renewed calls to abandon it following his admission of discomfort.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
